IL91423A - Preparation for the treatment of blood clots - Google Patents

Preparation for the treatment of blood clots

Info

Publication number
IL91423A
IL91423A IL9142389A IL9142389A IL91423A IL 91423 A IL91423 A IL 91423A IL 9142389 A IL9142389 A IL 9142389A IL 9142389 A IL9142389 A IL 9142389A IL 91423 A IL91423 A IL 91423A
Authority
IL
Israel
Prior art keywords
leu
ala
gin
ser
pro
Prior art date
Application number
IL9142389A
Other languages
English (en)
Hebrew (he)
Other versions
IL91423A0 (en
Original Assignee
Chugai Seiyaku Kabishiki Kaish
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabishiki Kaish filed Critical Chugai Seiyaku Kabishiki Kaish
Publication of IL91423A0 publication Critical patent/IL91423A0/xx
Publication of IL91423A publication Critical patent/IL91423A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Networks Using Active Elements (AREA)
  • Surgical Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL9142389A 1988-08-24 1989-08-24 Preparation for the treatment of blood clots IL91423A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21037688 1988-08-24

Publications (2)

Publication Number Publication Date
IL91423A0 IL91423A0 (en) 1990-04-29
IL91423A true IL91423A (en) 1995-06-29

Family

ID=16588321

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9142389A IL91423A (en) 1988-08-24 1989-08-24 Preparation for the treatment of blood clots

Country Status (8)

Country Link
US (1) US5202117A (de)
EP (1) EP0355811B1 (de)
KR (1) KR950003492B1 (de)
AT (1) ATE97813T1 (de)
CA (1) CA1339071C (de)
DE (1) DE68911061T2 (de)
IL (1) IL91423A (de)
ZA (1) ZA896463B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
FR2693907B1 (fr) * 1992-07-23 1994-09-02 Rhone Poulenc Rorer Sa Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires.
US5879794A (en) * 1994-08-25 1999-03-09 W. L. Gore & Associates, Inc. Adhesive-filler film composite
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
WO1998020528A1 (en) 1996-11-08 1998-05-14 W.L. Gore & Associates, Inc. METHOD FOR IMPROVING RELIABILITY OF THIN CIRCUIT SUBSTRATES BY INCREASING THE Tg OF THE SUBSTRATE
WO1999044630A1 (fr) * 1998-03-06 1999-09-10 Chugai Seiyaku Kabushiki Kaisha Preparations exemptes de proteines
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
US20020198150A1 (en) * 2001-06-07 2002-12-26 Ayelet Chajut Methods of using colony stimulating factors in the treatment of tissue damage and ischemia
AU2003261723A1 (en) 2002-08-27 2004-03-19 Takeda Chemical Industries, Ltd. Cxcr4 antagonist and use thereof
US20090226397A1 (en) * 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
KR100812274B1 (ko) * 2006-10-30 2008-03-13 한양대학교 산학협력단 G-csf를 유효성분으로 하는 당뇨성 말초신경병 예방 및치료제
US8455450B2 (en) 2006-12-21 2013-06-04 Biokine Therapeutics Ltd. Methods for obtaining a therapeutically effective amount of hematopoietic precursor cells and long term engraftment thereof
CN101939443B (zh) 2008-02-08 2014-01-29 Ambrx公司 经修饰瘦素多肽和其用途
PT2318029T (pt) * 2008-07-23 2018-01-10 Ambrx Inc Polipéptidos de g-csf bovino modificados e suas utilizações
US9155780B2 (en) 2009-02-11 2015-10-13 Yeda Research And Development Co. Ltd. Short beta-defensin-derived peptides
ES2462517T3 (es) 2009-06-14 2014-05-23 Biokine Therapeutics Ltd. Terapia con péptidos para aumentar los niveles de plaquetas
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
EP2841084B1 (de) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Cxcr4 antagonist peptid zur verwendung in der behandlung von lungenkrebs
AU2016291817A1 (en) 2015-07-16 2018-02-22 Biolinerx Ltd. Compositions and methods for treating cancer
CA3014530A1 (en) 2016-02-23 2017-08-31 Biolinerx Ltd. Methods of treating acute myeloid leukemia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
US5120534A (en) * 1988-07-29 1992-06-09 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and medicament for treating thrombocytopenia
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤

Also Published As

Publication number Publication date
CA1339071C (en) 1997-07-29
EP0355811A3 (de) 1991-03-20
US5202117A (en) 1993-04-13
KR900002800A (ko) 1990-03-23
AU4014789A (en) 1990-03-01
AU625914B2 (en) 1992-07-16
EP0355811B1 (de) 1993-12-01
EP0355811A2 (de) 1990-02-28
DE68911061D1 (de) 1994-01-13
KR950003492B1 (ko) 1995-04-13
ATE97813T1 (de) 1993-12-15
DE68911061T2 (de) 1994-03-24
IL91423A0 (en) 1990-04-29
ZA896463B (en) 1990-05-30

Similar Documents

Publication Publication Date Title
CA1339071C (en) Thrombus control agent
EP0506757B2 (de) Rekombinanter abkömmling des menschlichen faktors iii
EP0123304B1 (de) Verfahren zur Stabilisierung eines Gewebeplasminogenaktivators und diesen enthaltende stabile wässrige Lösung oder Pulver
US5112609A (en) Acidic formulations of t-PA
US4968617A (en) Solid hydrochloride salt of t-PA
EP0326014A1 (de) Zusammensetzung aus Antikoagulantia
CA1338698C (en) Process for the preparation of a solution of high concentration of a protein having tissue plasminogen activator (t-pa) activity, a solution containing protein having t-pa activity and the use of the solution in human and veterinary medicine
US7070958B2 (en) Methods of making pro-urokinase mutants
CA1308377C (en) Complex of polyethyleneglycol and tissue plasminogen activator
JP2907447B2 (ja) 抗血栓剤
EP0691850B1 (de) Faktor XIII zur Behandlung von Hautwunden
EP0151996B1 (de) Verfahren zur Herstellung eines doppelkettigen Plasminogenaktivators
JP2589094B2 (ja) 抗悪性腫瘍剤
US20020151481A1 (en) MMP-2 propeptide for use as antiangiogenic or antitumor agent
JPH0369332B2 (de)
JP2697725B2 (ja) 悪性腫瘍治療用キット
EP0352897A1 (de) TPA enthaltende Arzneimittel

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees